Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 45–45 | Cite as

Anaplastic lymphoma kinase inhibitors

Drug resistance: 35 case reports
Case report
  • 19 Downloads

Reference

  1. Yu Y, et al. Concomitant resistance mechanisms to multiple tyrosine kinase inhibitors in ALK-positive non-small cell lung cancer. Lung Cancer 127: 19-24, Jan 2019 - ChinaCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations